| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050696683 |
| P356 | DOI | 10.1186/1471-2407-8-58 |
| P932 | PMC publication ID | 2275285 |
| P698 | PubMed publication ID | 18294404 |
| P5875 | ResearchGate publication ID | 5558658 |
| P2093 | author name string | Fen-Pi Chou | |
| Hsing-Chun Kuo | |||
| Fung-Jou Lu | |||
| Tseng-Hsi Lin | |||
| P2860 | cites work | The molecular mechanisms of arsenic-induced cell transformation and apoptosis | Q24812452 |
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| The MAPK signaling cascade | Q28292599 | ||
| Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins | Q28344657 | ||
| Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia | Q28370464 | ||
| Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway | Q28372372 | ||
| Inhibition of chemical carcinogenesis by berberine in rats and mice | Q43615918 | ||
| Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver | Q44204335 | ||
| Arsenic trioxide arrests cells early in mitosis leading to apoptosis | Q44215116 | ||
| Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells | Q45020394 | ||
| Differentiated rat glial cell strain in tissue culture | Q47810508 | ||
| Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples | Q48165925 | ||
| Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. | Q48908809 | ||
| Cell transformation, invasion, and angiogenesis: a regulatory role for ornithine decarboxylase and polyamines? | Q53753522 | ||
| Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. | Q55475243 | ||
| The role of protein kinase Calpha in U-87 glioma invasion. | Q55476472 | ||
| Activation of PKC is required for arsenite-induced signal transduction | Q63561113 | ||
| Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells | Q74462112 | ||
| Anti-proliferative activity of protein kinase C in apical compartments of human colonic crypts: evidence for a less activated protein kinase C in small adenomas | Q77959511 | ||
| Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia | Q82916782 | ||
| Arsenic-induced apoptosis in malignant cells in vitro | Q28373408 | ||
| High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells | Q33937259 | ||
| Acute and chronic arsenic toxicity | Q34219547 | ||
| Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies | Q34237621 | ||
| The anti-inflammatory potential of berberine in vitro and in vivo | Q34290953 | ||
| Apoptosis induction by arsenic: mechanisms of action and possible clinical applications for treating therapy-resistant cancers | Q34332758 | ||
| Arsenic compounds as anticancer agents | Q34392105 | ||
| Cardiovascular actions of berberine | Q34405291 | ||
| Arsenic trioxide, a therapeutic agent for APL. | Q34435492 | ||
| Mechanisms of action of arsenic trioxide. | Q34525425 | ||
| Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? | Q34537883 | ||
| The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects | Q34581717 | ||
| Expanding the use of arsenic trioxide: leukemias and beyond | Q34638619 | ||
| Anti-cancer drugs of today and tomorrow: are we close to making the turn from treating to curing cancer? | Q34779987 | ||
| Arsenic trioxide: acute promyelocytic leukemia and beyond | Q34980350 | ||
| Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer | Q35117571 | ||
| Molecular mechanisms of glioma invasiveness: the role of proteases | Q35166808 | ||
| Protein kinase C: a target for anticancer drugs? | Q35540782 | ||
| Proteases in brain tumour progression | Q35541218 | ||
| The role of protein kinase C-alpha in malignancies of the nervous system and implications for the clinical development of the specific PKC-alpha inhibitor aprinocarsen (Review). | Q35626906 | ||
| Protein kinase C isozymes as potential targets for anticancer therapy | Q35699082 | ||
| Membrane type-matrix metalloproteinases and tumor progression. | Q36076513 | ||
| Protein kinase C and the regulation of the actin cytoskeleton | Q36234425 | ||
| Preclinical and clinical development of novel agents that target the protein kinase C family | Q36557306 | ||
| Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy | Q36710406 | ||
| Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. | Q39574246 | ||
| Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. | Q40290758 | ||
| Effects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cells | Q40298977 | ||
| Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. | Q40334903 | ||
| Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. | Q40361126 | ||
| Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells | Q40367873 | ||
| Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells | Q40392155 | ||
| Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo | Q40424299 | ||
| Review article: anti-diarrhoeal pharmacology and therapeutics | Q40441556 | ||
| Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. | Q40494548 | ||
| Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro. | Q40500887 | ||
| Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells | Q40801668 | ||
| Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to gamma-radiation and BCNU. | Q40925894 | ||
| Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor | Q41046634 | ||
| Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C | Q41600478 | ||
| The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy | Q41688724 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell migration | Q189092 |
| neoplastic invasiveness | Q112498967 | ||
| P304 | page(s) | 58 | |
| P577 | publication date | 2008-02-25 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide | |
| P478 | volume | 8 |
| Q33659224 | Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer |
| Q35143916 | Anti-cancer natural products isolated from chinese medicinal herbs |
| Q64268715 | Antitumor Effects of Berberine on Gliomas via Inactivation of Caspase-1-Mediated IL-1β and IL-18 Release |
| Q39656540 | Antitumor progression potential of caffeic acid phenethyl ester involving p75NTR in C6 glioma cells |
| Q42704760 | Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer. |
| Q39503929 | Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production |
| Q60935363 | Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma |
| Q38824752 | Berberine Increases Doxorubicin Sensitivity by Suppressing STAT3 in Lung Cancer |
| Q33954876 | Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes |
| Q39259358 | Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase |
| Q34995160 | Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells |
| Q38242945 | Berberine, an epiphany against cancer. |
| Q37788220 | Berberine: a potential phytochemical with multispectrum therapeutic activities |
| Q28538682 | Bidirectional functions of arsenic as a carcinogen and an anti-cancer agent in human squamous cell carcinoma |
| Q42157221 | CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure |
| Q55662423 | Cell-specific pattern of berberine pleiotropic effects on different human cell lines. |
| Q36371185 | Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells. |
| Q50041669 | Ethanol extract of Lycopodium serratum Thunb. Attenuates lipopolysaccharide-induced C6 glioma cells migration via matrix metalloproteinase-9 expression. |
| Q64964745 | Eupatilin inhibits glioma proliferation, migration, and invasion by arresting cell cycle at G1/S phase and disrupting the cytoskeletal structure. |
| Q48463254 | Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor |
| Q53494288 | Inhibition of invasion and migration of salivary gland adenocarcinoma cells by 5'-nitro-indirubinoxime (5'-NIO). |
| Q53130900 | Interaction of herbal compounds with biological targets: a case study with berberine. |
| Q90061190 | Methods for in vitro modeling of glioma invasion: Choosing tools to meet the need |
| Q39653380 | MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. |
| Q34249170 | Proteomic analysis of the effects of baicalein on colorectal cancer cells |
| Q30457889 | Room-temperature super-extraction system (RTSES) optimizes the anxiolytic- and antidepressant-like behavioural effects of traditional Xiao-Yao-San in mice |
| Q39463690 | Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line. |
| Q39288566 | The Unwanted Cell Migration in the Brain: Glioma Metastasis. |
| Q39036566 | The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma |
| Q38370031 | Therapeutic potential of berberine against neurodegenerative diseases |
| Q33508698 | Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9. |
| Q39659095 | Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma |
Search more.